Skip to main content
Transparency Guidelines
COVID-19
Who We Are
Our Industry
Resources
Login
Resources
Submissions
See all
PHARMAC Consultation: Proposal (dated 1 Oct 2020) to decline inactive funding applications 30 October 2020
30.10.20
Read more
Medsafe Consultation: Revisions to Part 10 of the GRTPNZ
20.10.20
Read more
PHARMAC Consultation: Proposal to modify PHARMAC’s approach to competitive procurement
23.07.20
Read more
Medsafe Consultation: Revisions to Part 8 of the GRTPNZ
15.07.20
Read more
Medsafe Consultation: Proposed Warning Statement for Substances in Medicines
08.08.19
Read more
PHARMAC Consultation: Proposal to decline inactive applications
21.05.19
Read more
Medsafe Consultation: Update to the Guideline on the Regulation of Therapeutic Products – Part 11: Clinical Trials
08.10.18
Read more
Medsafe Consultation: Review of fees payable under the Medicines Regulation 1984
27.04.18
Read more
Publications
See all
Funding Medicines in New Zealand: Revision of the Medicines Waiting List to 30 April 2020
17.09.20
Read more
New Zealand's Medicines Landscape 2019/20
30.06.20
Read more
Public Perceptions of Medicines Funding in New Zealand - Key Findings of two National Online Surveys
15.06.20
Read more
Access to Medicines (AtoM 2) Report 2020
11.06.20
Read more
NZIER A new generation medicines policy - discussion document
26.05.20
Read more
NZIER The value of clinical research with modern medicines in New Zealand
20.05.20
Read more
NZIER Establishment of a medicines appropriation
20.05.20
Read more
NZIER Rapid access to new medicines in New Zealand
20.05.20
Read more
Media Releases
See all
PHARMAC Inquiry: “nothing should be off the table”
04.12.20
Read more
Collaborative Consultation on Medicines Policy Closes
10.07.20
Read more
Solutions for the Future: A New Medicines Landscape
30.06.20
Read more
It’s time to put fairness into focus
19.06.20
Read more
Dire findings - NZ continues to rank last for modern medicines access
15.06.20
Read more
Medicines New Zealand consulting on a new generation medicines policy
26.05.20
Read more
Clinical trials of medicines worth more than $1.2 billion to New Zealand
21.05.20
Read more
New Zealand’s medicines system still on life-support but can be saved
11.05.20
Read more
